Home > Insider Trading > Filing (0001209191-21-055748)

Filing Details

Accession Number:: 0001209191-21-055748
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-09-13 19:04:47
Reporting Period:: 2021-09-09

Accepted Time:: 2021-09-13 19:04:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1679363	Morphic Holding Inc.	MORF	Pharmaceutical Preparations (2834)	473878772

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1780273	Bruce Rogers	C/O Morphic Holding, Inc. 35 Gatehouse Drive, A2 Waltham MA 02451	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-09-09	30,000	$4.32	119,905	No	4	M	Direct
Common Stock	Disposition	2021-09-09	1,701	$59.99	118,204	No	4	S	Direct
Common Stock	Disposition	2021-09-09	22,213	$60.87	95,991	No	4	S	Direct
Common Stock	Disposition	2021-09-09	6,086	$61.60	89,905	No	4	S	Direct
Common Stock	Acquisiton	2021-09-10	8,279	$4.32	98,184	No	4	M	Direct
Common Stock	Disposition	2021-09-10	8,279	$65.11	89,905	No	4	S	Direct
Common Stock	Acquisiton	2021-09-13	1,721	$4.32	91,626	No	4	M	Direct
Common Stock	Disposition	2021-09-13	1,721	$65.00	89,905	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy Common Stock)	Disposition	2021-09-09	30,000	$0.00	30,000	$4.32
Common Stock	Stock Option (right to buy Common Stock)	Disposition	2021-09-10	8,279	$0.00	8,279	$4.32
Common Stock	Stock Option (right to buy Common Stock)	Disposition	2021-09-13	1,721	$0.00	1,721	$4.32

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
190,713	2028-12-14	No	4	M	Direct
182,434	2028-12-14	No	4	M	Direct
180,713	2028-12-14	No	4	M	Direct

Footnotes

Includes 56 shares of Common Stock acquired under the issuer's employee stock purchase plan on August 31, 2021.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.42 to $60.36 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.42 to $61.41 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.42 to $61.82 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.53 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.12 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vests as to 2.0833% of the total shares monthly, beginning January 14, 2019, with 100% of the total shares vested and exercisable on December 14, 2022, subject to the reporting person's provision of service to the issuer on each vesting date.